Anxiety and depression in Multiple Sclerosis (MS): Antecedents, consequences, and differential impact on well-being and quality of life
- PMID: 32585615
- PMCID: PMC7719086
- DOI: 10.1016/j.msard.2020.102261
Anxiety and depression in Multiple Sclerosis (MS): Antecedents, consequences, and differential impact on well-being and quality of life
Abstract
Background: Individuals with multiple sclerosis (MS) are often plagued by the unpredictability of their disease and have to contend with uncertainty in their life and significant life changes. This can lead to high levels of stress, perceived lack of control, helplessness, and anxiety. Despite these circumstances, anxiety disorders are often overshadowed by depression, which can result in its presence being overlooked and undertreated by many medical professionals.
Methods: One hundred and eighty three individuals with MS completed a comprehensive online survey assessing depression and anxiety and the demographic and disease risk factors of such, including social support and substance use. Participants also completed measures of MS symptomatology, disease management, psychological well-being, and quality of life to determine the impact of depression and anxiety on outcomes associated with MS.
Results: Findings suggest that both depression and anxiety are prevalent in MS and related to many outcomes. However, based on comparisons of the associations and group comparisons, with a few exceptions, anxiety proved to more impactful than depression when examining these outcomes. When evaluating the risk factors/contributors of anxiety and depression, social support was a consistent predictor. Younger age and shorter disease duration were also associated with anxiety, while lower education and substance use were predictors of depression.
Conclusion: Findings suggest that attention to anxiety be given as much as depression as it plays a large role in individuals' perceived health and well-being, which subsequently impacts the severity of symptoms and overall quality of life. Early identification of anxiety and potential substance use and increased social support also appear to be crucial for mitigating the impact of depression and anxiety.
Keywords: Anxiety; Depression; Social support; Substance use; Well-being.
Copyright © 2020 Elsevier B.V. All rights reserved.
Conflict of interest statement
The Authors declare that there is no conflict of interest.
Figures




Similar articles
-
Coping strategies and quality of life in Mexican multiple sclerosis patients: Physical, psychological and social factors relationship.Mult Scler Relat Disord. 2018 Oct;25:122-127. doi: 10.1016/j.msard.2018.06.001. Epub 2018 Jun 26. Mult Scler Relat Disord. 2018. PMID: 30071505
-
Anxiety in Argentinian patients with multiple sclerosis: Prevalence and associated factors.Mult Scler Relat Disord. 2020 Jun;41:102042. doi: 10.1016/j.msard.2020.102042. Epub 2020 Mar 4. Mult Scler Relat Disord. 2020. PMID: 32163755
-
Factors associated with perceived need for mental health care in multiple sclerosis.Mult Scler Relat Disord. 2018 Oct;25:179-185. doi: 10.1016/j.msard.2018.07.043. Epub 2018 Jul 29. Mult Scler Relat Disord. 2018. PMID: 30096684
-
The effects of stressful life events on the course of multiple sclerosis: a review.Int J Neurosci. 2009;119(3):315-35. doi: 10.1080/00207450802480192. Int J Neurosci. 2009. PMID: 19116839 Review.
-
[Characteristics of anxiety disorders--prevalence among patients with sclerosis multiple, treatment options and effect on rehabilitation].Pol Merkur Lekarski. 2009 Dec;27(162):532-4. Pol Merkur Lekarski. 2009. PMID: 20120724 Review. Polish.
Cited by
-
Explaining the facilitators of quality of life in patients with multiple sclerosis: a qualitative study.BMC Neurol. 2021 May 11;21(1):193. doi: 10.1186/s12883-021-02213-9. BMC Neurol. 2021. PMID: 33975555 Free PMC article.
-
The impact of cognitive functions, psychological disorders, and coping strategies on quality of life and disease outcomes in patients with inflammatory bowel diseases: A cross-sectional study.Medicine (Baltimore). 2024 Jul 26;103(30):e38982. doi: 10.1097/MD.0000000000038982. Medicine (Baltimore). 2024. PMID: 39058817 Free PMC article.
-
The Path from Personality to Anxiety and Depression Is Mediated by Cognition in Multiple Sclerosis.J Pers Med. 2024 Jun 25;14(7):682. doi: 10.3390/jpm14070682. J Pers Med. 2024. PMID: 39063936 Free PMC article.
-
Aging and the neuropsychiatry of multiple sclerosis: a cross-sectional study.J Neurol. 2025 May 4;272(5):375. doi: 10.1007/s00415-025-13116-x. J Neurol. 2025. PMID: 40319422
-
Understanding the Effect of Multiple Sclerosis on General and Dimensions of Mental Health.J Clin Med. 2022 Dec 16;11(24):7483. doi: 10.3390/jcm11247483. J Clin Med. 2022. PMID: 36556099 Free PMC article.
References
-
- Shnek ZM, Foley FW, LaRocca NG, Smith CR, Halper J. Psychological predictors of depression in multiple sclerosis. Neurorehabilitation and Neural Repair 1995; 9(1): 15–23.
-
- Amato M, Ponziani G. A prospective study on the prognosis of multiple sclerosis. Neurological Sciences 2000; 21(2): S831–S8. - PubMed
-
- Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003; 126(4): 770–82. - PubMed
-
- Boeschoten RE, Braamse AM, Beekman AT, et al. Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis. Journal of the neurological sciences 2017; 372: 331–41. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical